The study will follow a group of volunteers using mPower, telehealth and fitness trackers. The researchers aim to collect decades worth of Parkinson’s data, according to a May 10 URMC news release. More than 225 patients agreed to participate in the study and will be followed for three years, building on two previous clinical trials.
The study will focus on mid-stage Parkinson’s with the aim of giving researchers precise ways to measure the impact of experimental therapies on this group of patients.
“COVID-19 disrupted clinical research and highlighted the need for tools to conduct remote clinical trials,” Ruth Schneider, MD, principal investigator of the new study and an associate professor in the URMC Department of Neurology, said in the news release. “These same tools are now enabling us to conduct decentralized clinical trials and develop digital measures to better understand and improve treatment of this complex disease.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
